These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Ongoing||2017-004577-14||Single cycle of blinatumomab followed by high-dose chemotherapy in the induction therapy for Ph-negative acute lymphoblastic leukemia in adults. Jeden cyklus blinatumomabu následovaný vysokodávkova...||not-yet-due|
|Ongoing||2019-004540-29||Ponatinib plus reduced-intensity chemotherapy in the first-line treatment of adult patients with Ph-positive acute lymphoblastic leukemia Ponatinib v kombinaci s redukovanou chemoterapií v první li...||not-yet-due|